10-K: Pennant Group Reports 15% Revenue Increase in 2023 Driven by Organic Growth and Strategic Acquisitions
Annual Results
The Pennant Group, Inc. saw a 15% revenue increase in 2023, fueled by organic growth across all segments and strategic acquisitions in home health, hospice, and senior living.
Summary
- The Pennant Group, Inc. reported a 15.1% increase in total revenue, reaching $544.9 million in 2023, compared to $473.2 million in 2022.
- This growth was primarily driven by a 12.3% organic increase in existing operations and a 2.8% increase from acquired operations.
- Home health and hospice services revenue increased by 15.3%, totaling $394.5 million, while senior living services revenue grew by 14.8% to $150.4 million.
- The company's home health agencies achieved an average of 4.1 out of 5 stars in CMS quality ratings, compared to the industry average of 3.0 stars.
- The company operates 111 home health and hospice agencies and 51 senior living communities across 13 states as of December 31, 2023.
- The company's blended payor mix was 48.4% Medicare, 14.2% Medicaid, 13.5% managed care, and 23.9% private pay for the year ended December 31, 2023.
Sentiment
Score: 8
Explanation: The document presents a positive outlook with strong revenue growth and quality metrics, but also acknowledges risks and challenges. The overall tone is optimistic and confident.
Positives
- The company experienced significant organic growth across all segments.
- Strategic acquisitions contributed to revenue growth.
- The company's home health agencies outperformed the industry average in CMS quality ratings.
- The company has a diversified portfolio of services and payors.
- The company has a strong focus on developing local leaders and empowering them to make decisions.
Negatives
- The company's cost of services increased by 16.3%, outpacing revenue growth.
- The company's effective tax rate increased from 18.5% to 29.0% due to a change in non-deductible equity compensation expenses.
- The company is subject to various government reviews, audits, and investigations that could adversely affect its business.
Risks
- Changes in Medicare and Medicaid reimbursement rates could negatively impact revenue.
- Increased competition for nurses and other skilled personnel could increase staffing costs.
- Security breaches and other cyber-security incidents could subject the company to significant liability.
- The company is subject to various government reviews, audits and investigations that could adversely affect its business.
- The company may be unable to complete future acquisitions at attractive prices or at all.
Future Outlook
The company plans to continue to grow its revenue and earnings by expanding existing operations and acquiring additional operations in existing and new markets. The company believes it is well-positioned to benefit from favorable demographic shifts and industry trends that reward providers offering quality care in lower cost settings.
Management Comments
- The company strives to be the provider of choice in the communities it serves through its innovative operating model.
- The company believes healthcare should be operated primarily as a local business.
- The company's local leaders are trained to identify opportunities for long-term organic growth.
Industry Context
The healthcare sector is one of the largest and fastest-growing sectors of the U.S. economy. The home health and hospice segment is growing within the overall healthcare landscape in the United States. The senior living market is also expected to expand. The company believes it is well-positioned to benefit from these trends.
Comparison to Industry Standards
- The company's home health agencies achieved an average of 4.1 out of 5 stars in CMS quality ratings, compared to the industry average of 3.0 stars, indicating a higher quality of care than many competitors.
- The company's diversified portfolio of services and payors provides greater business stability compared to companies focused on a single service or payor type.
- The company's innovative operating model, which emphasizes local decision-making and peer accountability, is unique among healthcare and senior living providers.
Legal Proceedings
- The company is involved in various claims and lawsuits arising in the ordinary course of business, none of which, in the opinion of management, is expected to have a material adverse effect on our results of operations or financial condition.
Related Party Transactions
- The company leases 29 senior living communities from subsidiaries of Ensign under a master lease arrangement.
- The company incurred $1,035, $1,561, and $3,124 in costs related to the Transitions Services Agreement for the years ended December 31, 2023, 2022 and 2021, respectively, that related primarily to shared services at proximate operations.
- Expenses related to room and board charges at Ensign skilled nursing facilities for hospice patients were $4,583, $3,211, and $3,084 for the years ended December 31, 2023, 2022 and 2021, respectively.
Stakeholder Impact
- Shareholders: The company's strong revenue growth and positive outlook are likely to be viewed favorably by shareholders.
- Employees: The company's focus on developing local leaders and creating a positive work environment may improve employee satisfaction and retention.
- Customers: The company's commitment to quality care and patient satisfaction is likely to benefit patients and residents.
- Suppliers: The company's growth may lead to increased demand for supplies and services.
- Creditors: The company's strong financial performance may improve its creditworthiness.
Next Steps
- The company plans to continue to drive organic growth and acquire additional operations in existing and new markets.
- The company will continue to expand formal and informal partnerships across the healthcare continuum.
- The company will continue to invest in programs and data analytics that help improve care transitions, achieve better outcomes and reduce costs.
Key Dates
| Date | Description |
|---|---|
| January 24, 2019 | The Pennant Group, Inc. was incorporated as a Delaware corporation. |
| October 1, 2019 | Ensign completed the separation of Pennant (the Spin-Off). |
| December 12, 2022 | The Board of Directors approved a share repurchase program. |
| June 12, 2023 | Pennant entered into the Second Amendment to its existing credit agreement. |
| December 31, 2023 | Fiscal year end. |
| February 27, 2024 | Date of share count and market value calculation. |
| February 28, 2024 | Date of the report. |
Keywords
home health, hospice, senior living, healthcare services, acquisitions, Medicare, Medicaid, revenue growth, quality care, operating model
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.